WO2000073254A1 - Concentration and purification of polyunsaturated fatty acid esters by distillation-enzymatic transesterification coupling - Google Patents

Concentration and purification of polyunsaturated fatty acid esters by distillation-enzymatic transesterification coupling Download PDF

Info

Publication number
WO2000073254A1
WO2000073254A1 PCT/CA2000/000643 CA0000643W WO0073254A1 WO 2000073254 A1 WO2000073254 A1 WO 2000073254A1 CA 0000643 W CA0000643 W CA 0000643W WO 0073254 A1 WO0073254 A1 WO 0073254A1
Authority
WO
WIPO (PCT)
Prior art keywords
process according
esters
alcohol
fatty acid
fatty acids
Prior art date
Application number
PCT/CA2000/000643
Other languages
French (fr)
Inventor
François Le Goffic
Anh Dung Nguyen
Chiraz Khayat-Frydman
Original Assignee
Jfs Envirohealth Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jfs Envirohealth Ltd. filed Critical Jfs Envirohealth Ltd.
Priority to EP00938359A priority Critical patent/EP1100764A1/en
Priority to JP2000621321A priority patent/JP2003500082A/en
Priority to AU53774/00A priority patent/AU5377400A/en
Publication of WO2000073254A1 publication Critical patent/WO2000073254A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/6445Glycerides
    • C12P7/6458Glycerides by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/6445Glycerides
    • C12P7/6472Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/03Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/48Separation; Purification; Stabilisation; Use of additives
    • C07C67/52Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C07C67/54Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation by distillation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/6445Glycerides
    • C12P7/6454Glycerides by esterification

Definitions

  • the present invention relates to a process for producing highly concentrated preparations of polyunsaturated fatty acids and their esters from oils from various sources, especially fish oils, vegetable oils and microalgae oils.
  • the process uses a combination of molecular distillation and selective enzymatic transesterification catalysed by upases which desirably can be immobilized.
  • fatty acids mostly encountered, usually as their triglyceride esters but not exclusively, in fish oils and vegetable oils are oleic acid (C18:l), palmitoleic acid (C16:l), palmitic acid (C16:0) and gadolenic acid (C20:l), but other fatty acids possessing from 14 to 24 carbon atoms in their structure, with or without double bounds, can also be found.
  • Polyunsaturated fatty acids possessing 3 double bonds or more are components of high economic value and have many applications in the pharmaceutical, nutrient and cosmetic fields.
  • Two well-known families are the so-called ⁇ 3 and ⁇ 6 families, which include a single double bond located three and six carbon atoms respectively from the terminal methyl group.
  • the two most important members of the ⁇ 3 family are eicosapentaenoic acid (EPA, C20:5) and docosahexenoic acid (DHA, C22:6) which play an important role in human physiology. They participate in the construction of cellular membranes and, as precursors of prostaglandins, in the formation of PGI3 and TxA3, which are extremely important factors for platelet aggregation prevention. Furthermore, DHA is the most important component of brain lipids and is believed to have a role in synaptic membrane functioning.
  • the principal members of the ⁇ family are ⁇ -linolenic (GLA, C18:3) acid and arachidonic acid (AA, C20:4). The former is an essential fatty acid and used for certain therapeutic purposes such as the treatment of multiple sclerosis. The latter participates in prostaglandin metabolism and possesses specific functions in brain and retina.
  • Fish oils are important sources for EPA and DHA.
  • the weight percentages of EPA+DHA of the total fatty acids range from 7% (in Pacific herring oil) to 28% (in Pacific squid oil) .
  • the most common source for EPA and DHA is sardine oil with a combined concentration of about 25%, comprising 18% EPA and 7% DHA.
  • Other possible sources are salmon oil (19% EPA and DHA), menhaden oil (24%), cod liver oil (24%), and mackerel oil (15%) .
  • the ratio of EPA to DHA in fish oils is usually about 2:1, but tuna oil contains about 5% EPA and about 18% DHA.
  • EPA and DHA are also found in lipids produced by marine microalgae such as Monodus subterraneus UTEX 151 (34.2% EPA), Chlorella minutissima UTEX 2341 (31.3% EPA), Crypthecodinium cohnii UTEX L1649 (19.9% DHA) or Amphidini um carterae UTEX LB 1002 (17% DHA) .
  • soybean and canola oils provide ⁇ linolenic acid (precursor of EPA and DHA) at 8-10% of the total fatty acids.
  • the major sources for ⁇ -linolenic acid are borage, evening primrose and black current oils. The first is more important with 20% to 23% of ⁇ -linolenic acid, while the second contains only about 10% of ⁇ -linolenic acid and the last 14% to 20%.
  • the composition of the reaction medium can be carefully controlled to purify selectively polyunsaturated fatty acids by the urea adduct formation method (Han, Daeseok; Shin, Hyun-Kyung; Yoon, Suk Hoo, ACS Symp. Ser. 1997, 674 (Flavor and Lipid Chemistry of Seafoods) ) .
  • EPA and DHA have also been purified through silver salt complexation (EP 454 430, and EP 303 668), by chromatography (Robles Medina, .; Gimenez Gimenez,A.; Garcia Camacho, F.; Sanchez Perez, J.A.; Molina Grima, E . ; Contreras Gomez, A.; J.Am.Oil Chem. Soc. 1995 72(5) 575-83). These processes result in the preparation of highly purified polyunsaturated fatty acids, but only in very small quantities.
  • the silver ion, Ag + can be immobilized on a clay mineral (Yamaguchi, Michihiro; Tanaka, Isao; Ohtsu, Yutaka; Yukagaku 1991 40(10), 959-64), which makes the method more practical.
  • a clay mineral Yamauchi, Michihiro; Tanaka, Isao; Ohtsu, Yutaka; Yukagaku 1991 40(10), 959-64
  • a very promising method currently used to obtain concentrates of polyunsaturated fatty acids is molecular distillation. This method makes use of high vacuum conditions to distil the thermolabile polyunsaturated fatty acids. This process, in some cases, results in very high concentrates of polyunsaturated fatty acids.
  • a British patent (GB 2 218 984) has claimed the process to be appropriate for industrial production of EPA and DHA. However multiple distillations are necessary to obtain a high concentration of polyunsaturated fatty acids and the distillation temperature used is very low (from 50 to 85°C) .
  • Using a low temperature has an advantage of not altering the nature of the easily oxidized polyunsaturated fatty acids, but causes a major problem in industrial production since the throughput is proportional to the difference between the vapour pressure of the products to be distilled and the operating pressure, and the former is a function of temperature.
  • molecular distillation Although very powerful, the concept of molecular distillation is close to that of batch distillation and thus has limitations. In particular, if the composition of the raw material is complex, molecular distillation does not allow an effective purification and for instance is inappropriate for the production of DHA free from EPA and vice versa. The same problem is encountered for the production of ⁇ -linolenic acid free from linoleic and oleic acids.
  • Another way to obtain polyunsaturated fatty acids in high concentration is selective hydrolysis or selective synthesis using specific enzymes.
  • Different upases known to have a selectivity for saturated fatty acids over polyunsaturated fatty acids are used.
  • the most common way is to hydrolyse oils containing polyunsaturated fatty acid triglycerides followed by washing or extraction (JP 05095792, JP 03108489, and JP 07203979) .
  • This invention seeks to provide an efficient economical process for the concentration and the purification of polyunsaturated fatty acids as onoesters of lower alcohols.
  • the raw material for the process is either fish oil containing different concentrations of eicosapentaenoic acid (EPA C20:5) and docosahexaenoic acid (DHA C22:6), or vegetable oils like borage, evening primrose or black current oils, containing different concentrations of ⁇ -linolenic acid (GLA C18:3), or oils isolated from microalgae or other micro-organisms which contain fatty acids like DHA or arachidonic acid (AA C20:4).
  • these desired acids are usually present in the natural oil as the triglyceride ester.
  • the fatty acid triglyceride ester is first transesterified chemically.
  • the esters are either submitted to fractionation concentration (EPA-DHA) prior to enzymatic transesterification catalysed by an appropriate enzyme, or directly enzymatically transesterified.
  • the course of the reaction is followed by gas chromatography. It is stopped by the removal of the enzyme by filtration or centrifugation.
  • the transesterified oil product is submitted, generally, to two molecular or so-called short path distillations.
  • the excess of transesterification alcohol is removed as distillate, and the oil is also deodorized.
  • a distillate is produced comprising the unsaturated fatty acid ester of interest as a generally clear, odorless compound.
  • the residue of this distillation can also be used as a potential wax base, or split into its component fatty acids, or fatty acid esters of lower alcohols, which can also be purified by short path distillation.
  • this invention comprises a multistep process which can be summarised as follows.
  • Step 1 Oils containing polyunsaturated fatty acid triglycerides, such as sardine oil, borage oil and the like as described above, are first transesterified for three hours, with a primary lower alkyl alcohol at room temperature, using an alkali metal alcoholate of the same lower alkyl alcohol as catalyst. The esters obtained are separated from the glycerol formed during the reaction by decantation. The excess alcohol is removed under vacuum (15 bars) . The mixture is then treated according to its composition and to the polyunsaturated acids to be purified, using the following procedure.
  • Step 2 The mixture of ethyl esters is subjected to a preliminary optional short path distillation at 160-190°C and a pressure of 10 "3 bar to remove impurities, which constitute the distillation residue.
  • the distillate comprises the desired fatty acid ethyl esters.
  • Step 3 The distillate from step 2, or the esters mixture from step 1 if step 2 is omitted, is subjected to short path distillation at 130-160°C and a pressure of 10 "3 mbar to separate the mixture into two ester fractions.
  • the distillate is rich in esters of fatty acids possessing 18 carbons or less, and the distilland is rich in esters of fatty acids possessing 20 carbons or more.
  • Step 4 The purified ethyl esters from Step 3 are transesterified with a mono- or poly-alkoxy alcohol using a reaction specific lipase, in the presence of sufficient water for the lipase enzyme to catalyse the transesterification reaction, to provide a mixture of fatty acid ethyl esters rich in polyunsaturated fatty acids and fatty acid alkoxyalkyl esters rich in saturated and monounsaturated fatty acids .
  • Step 5 The unreacted alcohol remaining after the transesterification reaction in Step 4 is removed by short path distillation at 60-90°C under a pressure of 10 "3 mbar, or by washing with water followed by a suitable drying procedure.
  • Step 6 The esters mixture from Step 5 is subjected to a final short path distillation at 100-180°C to separate the fatty acid ethyl esters distillate from fatty acid alkoxy alkyl esters (distilland) .
  • steps 1 and 2 are not used in the purification of ⁇ -linolenic acid from borage oil as the principal constituents of this oil are linolenic, linoleic and oleic acids, which cannot be separated efficiently by distillation.
  • Step 4 is omitted whenever a too high molecular weight alcohol such as polyethylene glycol methyl ether 350 is used.
  • the primary lower alkyl alcohol preferably contains up to 7 carbon atoms, or can be benzyl alcohol. More preferably, the lower alkyl alcohol is ethyl alcohol.
  • step 4 the amount of enzyme used is preferably from about 0.5% to about 5.0% by weight of the fatty acid esters present in the oil, and the amount of water present is from 1% to 10% by weight of the enzyme.
  • the lipase enzyme is chosen from the group consisting of: Lipozyme IM from a Mucor miehei strain; Lipase D from a Rhizopus delemar strain; and Esterase 30000 from a Mucor miehei strain.
  • the transesterification in step 4 is carried out at a temperature of 50 - 70°C, and a pressure of from about 0.1 - 20 mbars. More preferably, the transesterification in step 4 is carried out at a temperature of 60 - 70°C, and a pressure of about 15 mbars.
  • the present invention provides a process to obtain polyunsaturated fatty acids on a large scale. It can be applied to different kinds of oils by coupling short path distillation and selective enzymatic transesterification.
  • the two techniques can be used in a modular way in order to obtain products with a desirable composition. The combination makes it possible for the following to be obtained:
  • thermolabile polyunsaturated fatty acid esters In any of the purification steps, whenever the product is subject to heating, for either a distillation step or in the enzymatic reaction, it is always under vacuum. This minimises any oxidation and the degradation of the thermolabile polyunsaturated fatty acid esters.
  • the polyunsaturated fatty acids are purified as ethyl esters, whose vapour pressure is higher than that of the corresponding free acids. This makes it possible to obtain a high throughput in the short path distillation steps at 130- Steps 1 and 2 are used principally for the purification of EPA and DHA.
  • the ethyl esters of these fatty acids have a much lower rate of distillation than that of lower fatty acids (C18, C16 and lower).
  • a preliminary distillation makes it possible to obtain products containing up to 33% EPA and 22% DHA, and eliminates a high proportion of the lower fatty acids which are also present.
  • the quantity of products to be treated enzymatically is therefore much smaller than the original material, usually from about 10% to about 20% of the starting material, according to its composition.
  • the key step of the whole procedure is the transesterification of the fatty acid ethyl esters with a mono - or polyalkoxy alcohol, such as 2- (2-butoxyethoxy) ethanol and polyethylene glycol methyl ether 350, using a reaction specific lipase such as Lipozyme IM (Novo) under a vacuum of 10-20 mbars, and at appropriate temperature, such as 60-70°C for Lipozyme) .
  • the reaction equilibrium is displaced by removing under vacuum the ethanol formed during the reaction.
  • the rate at which the enzyme catalyses the transesterification reaction depends on the degree of unsaturation of the fatty acid in the ethyl ester; the reaction generally becomes slower as the degree of unsaturation increases.
  • the fatty acid ethyl esters rich in polyunsaturated fatty acids are then separated from the products of the enzymatic reaction comprising the fatty acid alkoxyalkyl esters rich in saturated and monounsaturated fatty acids by a second short path distillation at 100-180°C under a pressure of 10 "3 mbars.
  • the fatty acid ethyl esters rich in polyunsaturated fatty acids are recovered in the distillate while the fatty acid alkoxyalkyl esters rich in saturated and monounsaturated fatty acids, whose vapour pressure is practically nil, are recovered as the distilland.
  • This short path distillation step is also used to remove the excess of alcohol if it has a zero vapour pressure, as in the case of polyethylene glycol.
  • the distillate product obtained is highly rich in polyunsaturated fatty acid ethyl esters, and can contain more than 80% in most cases and can reach 90% or more.
  • alkoxy alcohol is crucial for the purification.
  • the alkoxy alcohol esters formed by the enzymatic reaction cannot be distilled in the range of temperature used for the distillation of fatty acid ethyl esters and thus the two ester types can be separated very efficiently by short path distillation.
  • the enzyme selectivity is much higher with an alkoxy alcohol than with an aliphatic alcohol.
  • oleyl alcohol for example, the enzymatic transesterification by Lipozyme IM is practically the same for all the fatty acids while with polyethylene glycol methyl ether 350, the reaction rate for saturated and monounsaturated fatty acids esters is at least 12 times greater than that for EPA (C20:5) ester and DHA ester.
  • This characteristic allows not only the enrichment of polyunsaturated fatty acids but also the separation of DHA from EPA.
  • the mixture of fatty acid ethyl esters enriched in EPA and DHA is subject to a transesterification with polyethylene glycol methyl ether by Lipozyme IM to convert EPA into its ester with polyethylene glycol methyl ether, which is then separated from DHA ethyl ester by short path distillation.
  • EPA is recovered in its free form after a saponification or hydrolysis, or as an ester of a lower alcohol by a suitable transesterification reaction.
  • ⁇ -linolenic acid which is one of the polyunsaturated fatty acids in borage and evening primrose oils, can also be isolated by the above procedure.
  • 2- (2-butoxyethoxy) ethanol seems to be the best alcohol for the purification of ⁇ -linolenic acid ester, as ⁇ -linolenate ethyl ester with a concentration of up to 90% can be obtained at a yield of up to about 96%.
  • the product is then submitted to short path distillation at 160 °C under a pressure of 10 3 mbars, and about 9.5 kg of clear, limpid ethyl esters is obtained as the distillate, containing 18% EPA and 7% DHA as their ethyl esters.
  • the ethyl esters mixture is then submitted to short path distillation at 150 °C under a pressure of 10 ⁇ 3 mbars.
  • the distilland representing 15 to 30% of the throughput is recovered.
  • This product contains at least 28% to 40% EPA, and 20% to 35% DHA, as the ethyl esters. With more careful control, the process can produce 33% EPA and 22% DHA, as the ethyl esters.
  • distilland from this first distillation is distilled again at 100-120°C and gives rise to an odourless distillate. Both distillations are carried out a pressure of 10 "3 mbars. Analysis by gas chromatography reveals that a concentration of AA ethyl ester higher than 95% can be reached.
  • fatty acid ethyl esters containing 23% ⁇ -linolenic acid from borage oil
  • borage oil 100 parts by weight of fatty acid ethyl esters containing 23% ⁇ -linolenic acid (from borage oil) is transesterified with 600 to 800 parts by weight of 2- (2-butoxy ethoxy) ethanol and 6 to 10 parts of Lipozyme IM or lipase D from Rhizopus delemar or esterase 30000 from Mucor mihei strains, in one presence of sufficient water for the enzymatic reaction to proceed, under a vacuum of 9 to 15 mbars and at a temperature of 50-60°C. The reaction is stopped by removing the enzyme by filtration. The resulting oil is submitted to two short path distillations. In the first one, performed between 50°C and 60°C, excess alcohol is removed as distillate.
  • distilland residue thus obtained is subjected to a second distillation at 100-120°C. Both distillations are carried out at a pressure of 10 "3 mbar.
  • the distillate is recovered and analysed by gas chromatography. A clear odourless oil is obtained, which contains no less than 50% ⁇ -linolenic acid ethyl ester. This concentration can reach 90%.
  • a mixture of fatty acid ethyl esters from evening primrose oil is treated under the same conditions as in Example 4. After a few hours (between 2 and 4), the reaction is stopped and the oil treated as in Example .
  • the product comprises a ⁇ -linolenic acid ethyl ester concentrate containing between 25% and 40%. This concentration can be dramatically increased when longer reaction times are applied.

Abstract

A process for producing highly concentrated preparations of polyunsaturated fatty acids and their esters from oils, especially fish oils, in which they occur mainly as their triglyceride esters. The process uses a combination of transesterification of the triglycerides with a lower alkyl alcohol or benzyl alcohol, molecular distillation and selective enzymatic transesterification with an alkoxy alcohol catalysed by lipases which desirably can be immobilized. The process permits the separation of the acids mixture usually encountered in the oils, and isolation of desired acids in high yields. Typical acids which can be obtained by means of this process are eicosapentaenoic acid (EPA, C20:5) and docosahexaenoic acid (DHA, C22:6).

Description

CONCENTRATION AND PURIFICATION OF POLYUNSATURATED
FATTY ACID ESTERS BY DISTILLATION-ENZYMATIC
TRANSESTERIFICATION COUPLING
The present invention relates to a process for producing highly concentrated preparations of polyunsaturated fatty acids and their esters from oils from various sources, especially fish oils, vegetable oils and microalgae oils. The process uses a combination of molecular distillation and selective enzymatic transesterification catalysed by upases which desirably can be immobilized.
The fatty acids mostly encountered, usually as their triglyceride esters but not exclusively, in fish oils and vegetable oils are oleic acid (C18:l), palmitoleic acid (C16:l), palmitic acid (C16:0) and gadolenic acid (C20:l), but other fatty acids possessing from 14 to 24 carbon atoms in their structure, with or without double bounds, can also be found. Polyunsaturated fatty acids possessing 3 double bonds or more are components of high economic value and have many applications in the pharmaceutical, nutrient and cosmetic fields. Two well-known families are the so-called ω3 and ω6 families, which include a single double bond located three and six carbon atoms respectively from the terminal methyl group.
The two most important members of the ω3 family are eicosapentaenoic acid (EPA, C20:5) and docosahexenoic acid (DHA, C22:6) which play an important role in human physiology. They participate in the construction of cellular membranes and, as precursors of prostaglandins, in the formation of PGI3 and TxA3, which are extremely important factors for platelet aggregation prevention. Furthermore, DHA is the most important component of brain lipids and is believed to have a role in synaptic membrane functioning. The principal members of the ωβ family are γ-linolenic (GLA, C18:3) acid and arachidonic acid (AA, C20:4). The former is an essential fatty acid and used for certain therapeutic purposes such as the treatment of multiple sclerosis. The latter participates in prostaglandin metabolism and possesses specific functions in brain and retina.
Fish oils are important sources for EPA and DHA. In major marine oils of commerce, the weight percentages of EPA+DHA of the total fatty acids range from 7% (in Pacific herring oil) to 28% (in Pacific squid oil) . But the most common source for EPA and DHA is sardine oil with a combined concentration of about 25%, comprising 18% EPA and 7% DHA. Other possible sources are salmon oil (19% EPA and DHA), menhaden oil (24%), cod liver oil (24%), and mackerel oil (15%) . The ratio of EPA to DHA in fish oils is usually about 2:1, but tuna oil contains about 5% EPA and about 18% DHA. EPA and DHA are also found in lipids produced by marine microalgae such as Monodus subterraneus UTEX 151 (34.2% EPA), Chlorella minutissima UTEX 2341 (31.3% EPA), Crypthecodinium cohnii UTEX L1649 (19.9% DHA) or Amphidini um carterae UTEX LB 1002 (17% DHA) .
In vegetable oils, soybean and canola oils provide γ~ linolenic acid (precursor of EPA and DHA) at 8-10% of the total fatty acids. The major sources for γ-linolenic acid are borage, evening primrose and black current oils. The first is more important with 20% to 23% of γ-linolenic acid, while the second contains only about 10% of γ-linolenic acid and the last 14% to 20%.
Many methods have been proposed to obtain products enriched in polyunsaturated fatty acids using various techniques. Most have used urea complexion where the straight chain saturated fatty acids and most monoethylenic fatty acids are removed (US 4,792,418). This process can be followed by a fractional distillation to obtain EPA in high concentration (US 4,377,526) . A problem in using urea complexation is that the high quantity of urea necessary for the purification makes it difficult to produce the desired compounds on a large scale. On the other hand, the technique permits the concentration of various unsaturated fatty acids simultaneously. The composition of the reaction medium can be carefully controlled to purify selectively polyunsaturated fatty acids by the urea adduct formation method (Han, Daeseok; Shin, Hyun-Kyung; Yoon, Suk Hoo, ACS Symp. Ser. 1997, 674 (Flavor and Lipid Chemistry of Seafoods) ) .
EPA and DHA have also been purified through silver salt complexation (EP 454 430, and EP 303 668), by chromatography (Robles Medina, .; Gimenez Gimenez,A.; Garcia Camacho, F.; Sanchez Perez, J.A.; Molina Grima, E . ; Contreras Gomez, A.; J.Am.Oil Chem. Soc. 1995 72(5) 575-83). These processes result in the preparation of highly purified polyunsaturated fatty acids, but only in very small quantities. The silver ion, Ag+, can be immobilized on a clay mineral (Yamaguchi, Michihiro; Tanaka, Isao; Ohtsu, Yutaka; Yukagaku 1991 40(10), 959-64), which makes the method more practical.
Supercritical extraction and liquid-liquid extraction are also alternative techniques of purification (JP 09157684 and JP 09263787) .
A very promising method currently used to obtain concentrates of polyunsaturated fatty acids is molecular distillation. This method makes use of high vacuum conditions to distil the thermolabile polyunsaturated fatty acids. This process, in some cases, results in very high concentrates of polyunsaturated fatty acids. A British patent (GB 2 218 984) has claimed the process to be appropriate for industrial production of EPA and DHA. However multiple distillations are necessary to obtain a high concentration of polyunsaturated fatty acids and the distillation temperature used is very low (from 50 to 85°C) . Using a low temperature has an advantage of not altering the nature of the easily oxidized polyunsaturated fatty acids, but causes a major problem in industrial production since the throughput is proportional to the difference between the vapour pressure of the products to be distilled and the operating pressure, and the former is a function of temperature.
Although very powerful, the concept of molecular distillation is close to that of batch distillation and thus has limitations. In particular, if the composition of the raw material is complex, molecular distillation does not allow an effective purification and for instance is inappropriate for the production of DHA free from EPA and vice versa. The same problem is encountered for the production of γ-linolenic acid free from linoleic and oleic acids.
Another way to obtain polyunsaturated fatty acids in high concentration is selective hydrolysis or selective synthesis using specific enzymes. Different upases known to have a selectivity for saturated fatty acids over polyunsaturated fatty acids are used. The most common way is to hydrolyse oils containing polyunsaturated fatty acid triglycerides followed by washing or extraction (JP 05095792, JP 03108489, and JP 07203979) .
This invention seeks to provide an efficient economical process for the concentration and the purification of polyunsaturated fatty acids as onoesters of lower alcohols. The raw material for the process is either fish oil containing different concentrations of eicosapentaenoic acid ( EPA C20:5) and docosahexaenoic acid (DHA C22:6), or vegetable oils like borage, evening primrose or black current oils, containing different concentrations of γ-linolenic acid (GLA C18:3), or oils isolated from microalgae or other micro-organisms which contain fatty acids like DHA or arachidonic acid (AA C20:4). In general, these desired acids are usually present in the natural oil as the triglyceride ester.
In this invention the fatty acid triglyceride ester is first transesterified chemically. The esters are either submitted to fractionation concentration (EPA-DHA) prior to enzymatic transesterification catalysed by an appropriate enzyme, or directly enzymatically transesterified. The course of the reaction is followed by gas chromatography. It is stopped by the removal of the enzyme by filtration or centrifugation. The transesterified oil product is submitted, generally, to two molecular or so-called short path distillations.
In the first one, the excess of transesterification alcohol is removed as distillate, and the oil is also deodorized. In the second one, performed on the residue of the first distillation, a distillate is produced comprising the unsaturated fatty acid ester of interest as a generally clear, odorless compound. The residue of this distillation can also be used as a potential wax base, or split into its component fatty acids, or fatty acid esters of lower alcohols, which can also be purified by short path distillation.
In more detail, in a preferred embodiment this invention comprises a multistep process which can be summarised as follows. Step 1. Oils containing polyunsaturated fatty acid triglycerides, such as sardine oil, borage oil and the like as described above, are first transesterified for three hours, with a primary lower alkyl alcohol at room temperature, using an alkali metal alcoholate of the same lower alkyl alcohol as catalyst. The esters obtained are separated from the glycerol formed during the reaction by decantation. The excess alcohol is removed under vacuum (15 bars) . The mixture is then treated according to its composition and to the polyunsaturated acids to be purified, using the following procedure.
Step 2. The mixture of ethyl esters is subjected to a preliminary optional short path distillation at 160-190°C and a pressure of 10"3 bar to remove impurities, which constitute the distillation residue. The distillate comprises the desired fatty acid ethyl esters.
Step 3: The distillate from step 2, or the esters mixture from step 1 if step 2 is omitted, is subjected to short path distillation at 130-160°C and a pressure of 10"3 mbar to separate the mixture into two ester fractions. The distillate is rich in esters of fatty acids possessing 18 carbons or less, and the distilland is rich in esters of fatty acids possessing 20 carbons or more.
Step 4: The purified ethyl esters from Step 3 are transesterified with a mono- or poly-alkoxy alcohol using a reaction specific lipase, in the presence of sufficient water for the lipase enzyme to catalyse the transesterification reaction, to provide a mixture of fatty acid ethyl esters rich in polyunsaturated fatty acids and fatty acid alkoxyalkyl esters rich in saturated and monounsaturated fatty acids . Step 5: The unreacted alcohol remaining after the transesterification reaction in Step 4 is removed by short path distillation at 60-90°C under a pressure of 10"3 mbar, or by washing with water followed by a suitable drying procedure.
Step 6: The esters mixture from Step 5 is subjected to a final short path distillation at 100-180°C to separate the fatty acid ethyl esters distillate from fatty acid alkoxy alkyl esters (distilland) .
In the purification procedure, one or more steps can be bypassed if they are not necessary. For example, steps 1 and 2 are not used in the purification of γ-linolenic acid from borage oil as the principal constituents of this oil are linolenic, linoleic and oleic acids, which cannot be separated efficiently by distillation. Step 4 is omitted whenever a too high molecular weight alcohol such as polyethylene glycol methyl ether 350 is used.
In step 1 the primary lower alkyl alcohol preferably contains up to 7 carbon atoms, or can be benzyl alcohol. More preferably, the lower alkyl alcohol is ethyl alcohol.
In step 4 the amount of enzyme used is preferably from about 0.5% to about 5.0% by weight of the fatty acid esters present in the oil, and the amount of water present is from 1% to 10% by weight of the enzyme.
Preferably in step 3 the lipase enzyme is chosen from the group consisting of: Lipozyme IM from a Mucor miehei strain; Lipase D from a Rhizopus delemar strain; and Esterase 30000 from a Mucor miehei strain. Preferably, the transesterification in step 4 is carried out at a temperature of 50 - 70°C, and a pressure of from about 0.1 - 20 mbars. More preferably, the transesterification in step 4 is carried out at a temperature of 60 - 70°C, and a pressure of about 15 mbars.
The present invention provides a process to obtain polyunsaturated fatty acids on a large scale. It can be applied to different kinds of oils by coupling short path distillation and selective enzymatic transesterification. The two techniques can be used in a modular way in order to obtain products with a desirable composition. The combination makes it possible for the following to be obtained:
(a) products containing the desired fatty acids at very high concentrations which may reach 90% or higher in many cases, even with complex starting materials;
(b) products containing tailor-made compositions,
(c) very high yield and very high throughput in the purification sequence of steps;
(d) the purification process does not require the use of a solvent; and
(e) it is possible to separate EPA from DHA.
In any of the purification steps, whenever the product is subject to heating, for either a distillation step or in the enzymatic reaction, it is always under vacuum. This minimises any oxidation and the degradation of the thermolabile polyunsaturated fatty acid esters.
The polyunsaturated fatty acids are purified as ethyl esters, whose vapour pressure is higher than that of the corresponding free acids. This makes it possible to obtain a high throughput in the short path distillation steps at 130- Steps 1 and 2 are used principally for the purification of EPA and DHA. The ethyl esters of these fatty acids have a much lower rate of distillation than that of lower fatty acids (C18, C16 and lower). Thus a preliminary distillation makes it possible to obtain products containing up to 33% EPA and 22% DHA, and eliminates a high proportion of the lower fatty acids which are also present. The quantity of products to be treated enzymatically is therefore much smaller than the original material, usually from about 10% to about 20% of the starting material, according to its composition.
The key step of the whole procedure is the transesterification of the fatty acid ethyl esters with a mono - or polyalkoxy alcohol, such as 2- (2-butoxyethoxy) ethanol and polyethylene glycol methyl ether 350, using a reaction specific lipase such as Lipozyme IM (Novo) under a vacuum of 10-20 mbars, and at appropriate temperature, such as 60-70°C for Lipozyme) . The reaction equilibrium is displaced by removing under vacuum the ethanol formed during the reaction. The rate at which the enzyme catalyses the transesterification reaction depends on the degree of unsaturation of the fatty acid in the ethyl ester; the reaction generally becomes slower as the degree of unsaturation increases. Consequently, it is found that saturated and monounsaturated fatty acid ethyl esters are first transesterified, and the transesterification of polyunsaturated fatty acid ethyl esters takes place generally at a much lower rate. There remains however a difference of behaviour between EPA and DHA which is not recognized by the upases, and EPA reacts relatively slowly. After the transesterification process, a mixture of fatty acid ethyl esters rich in polyunsaturated fatty acids and fatty acid alkoxyalkyl esters rich in saturated and mono unsaturated fatty acids is obtained. After the transesterification step, the remaining excess alcohol can be suitably removed by short path distillation. As they possess usually a higher vapour pressure than that of the fatty acid esters, it is easy to separate them from the latter by a short path distillation at 60-90°C at a pressure of 10~3 mbars; under these conditions the distillation rate of the fatty acid esters is insignificant. Thus the alcohol is recovered as the distillate, and can be recycled.
The fatty acid ethyl esters rich in polyunsaturated fatty acids are then separated from the products of the enzymatic reaction comprising the fatty acid alkoxyalkyl esters rich in saturated and monounsaturated fatty acids by a second short path distillation at 100-180°C under a pressure of 10"3 mbars. The fatty acid ethyl esters rich in polyunsaturated fatty acids are recovered in the distillate while the fatty acid alkoxyalkyl esters rich in saturated and monounsaturated fatty acids, whose vapour pressure is practically nil, are recovered as the distilland. This short path distillation step is also used to remove the excess of alcohol if it has a zero vapour pressure, as in the case of polyethylene glycol.
The distillate product obtained is highly rich in polyunsaturated fatty acid ethyl esters, and can contain more than 80% in most cases and can reach 90% or more.
The choice of alkoxy alcohol is crucial for the purification. The alkoxy alcohol esters formed by the enzymatic reaction cannot be distilled in the range of temperature used for the distillation of fatty acid ethyl esters and thus the two ester types can be separated very efficiently by short path distillation. The enzyme selectivity is much higher with an alkoxy alcohol than with an aliphatic alcohol. With oleyl alcohol, for example, the enzymatic transesterification by Lipozyme IM is practically the same for all the fatty acids while with polyethylene glycol methyl ether 350, the reaction rate for saturated and monounsaturated fatty acids esters is at least 12 times greater than that for EPA (C20:5) ester and DHA ester. This characteristic allows not only the enrichment of polyunsaturated fatty acids but also the separation of DHA from EPA. The mixture of fatty acid ethyl esters enriched in EPA and DHA is subject to a transesterification with polyethylene glycol methyl ether by Lipozyme IM to convert EPA into its ester with polyethylene glycol methyl ether, which is then separated from DHA ethyl ester by short path distillation. EPA is recovered in its free form after a saponification or hydrolysis, or as an ester of a lower alcohol by a suitable transesterification reaction. γ-linolenic acid, which is one of the polyunsaturated fatty acids in borage and evening primrose oils, can also be isolated by the above procedure. 2- (2-butoxyethoxy) ethanol seems to be the best alcohol for the purification of γ-linolenic acid ester, as γ-linolenate ethyl ester with a concentration of up to 90% can be obtained at a yield of up to about 96%.
The present invention will now be illustrated by the following examples. In these examples, all analysis data was obtained by suitable chromatography procedures.
Example 1.
To 3 litres of absolute ethanol, 23 g of sodium are added. When all the sodium is dissolved, 10 kg of sardine oil, containing 18% EPA, and 7% DHA as triglycerides, is added. After 3 hours of reaction under agitation at ambient temperature and nitrogen atmosphere, the mixture is decanted, and the glycerol separated at the bottom of the mixture is removed. The ethyl esters solution is then dried and degassed under vacuum (10 mbars) . About 10 kg of products is recovered. The product is then submitted to short path distillation at 160 °C under a pressure of 103 mbars, and about 9.5 kg of clear, limpid ethyl esters is obtained as the distillate, containing 18% EPA and 7% DHA as their ethyl esters.
The ethyl esters mixture is then submitted to short path distillation at 150 °C under a pressure of 10~3 mbars. The distilland representing 15 to 30% of the throughput is recovered. This product contains at least 28% to 40% EPA, and 20% to 35% DHA, as the ethyl esters. With more careful control, the process can produce 33% EPA and 22% DHA, as the ethyl esters.
Example 2.
1000 parts by weight of fatty acid ethyl esters containing 33% EPA and 22% DHA obtained by the process of Example 1 is transesterified with 550 to 900 parts by weight of polyethylene glycol methyl ether MW 350 and 10 to 20 parts by weight of Lipozyme IM in one presence of sufficient water for the enzymatic reaction to proceed.. The reaction is carried out under vacuum at a pressure of 10 mbars over 24 hours at a temperature of 60°C. After the reaction is complete, the enzyme is separated by filtration and can be recycled if desired. The reaction product is submitted to short path distillation at 180°C under a pressure of 10-3 mbars. The distillate containing the unreacted fatty acid ethyl esters is recovered. Total concentration of EPA and DHA ethyl esters in this distillate is between 75 and 82% (EPA from 35 to 38%, DHA from 40 to 44%) .
Example 3.
1000 parts by weight of fatty acid ethyl esters containing 35% EPA and 40% DHA from Example 2 is transesterified with 700 to 850 parts by weight of polyethylene glycol methyl ether MW 350 and 20 to 50 parts by weight of Lipozyme IM in one presence of sufficient water for the enzymatic reaction to proceed under vacuum at a pressure of 10 mbars for 48 hours at a temperature of 60°C. After transesterification, the enzyme is separated, and the product is distilled by short path distillation at 180°C under a pressure of 10"3 mbars to obtain a distillate containing more than 90% DHA and less than 5% EPA, and a distilland containing more than 50% EPA. 100 parts by weight of the distilland is treated with 30 parts by weight of absolute ethanol containing 0.68 parts by weight of sodium ethanolate for 3 hours under nitrogen. The product is then washed with water and dried, to give a mixture of fatty acid ethyl esters containing more than 50% EPA and less than 2% DHA.
Example 4.
1000 parts by weight of fatty acid ethyl esters containing 20% DHA (from Crypthecodinium cohnii ) , 600 to 800 parts of 2- (2-butoxy ethoxy) ethanol, and 4 to 10 parts of Lipozyme IM are stirred and heated at between 50 and 60°C under a vacuum of 9 to 15 mbars for a few hours. The reaction is stopped by removing the enzyme by filtration, and then the oil is submitted to two short path distillations. The first one is performed between 50°C and 60°C and removes excess alcohol as well as odour, and the second one is at 100-120°C; both are carried out at 10"3 mbar. The distillate is collected and analysed by gas chromatography. A concentrate of docosahexaenoic acid ethyl ester which can reach 95% is obtained.
Example 5.
100 parts by weight of fatty acid ethyl esters containing 40% AA (arachidonic acid; C20:5), 600 to 800 parts of 2- (2- butoxy ethoxy) ethanol, and 4 to 10 parts of Lipozyme IM, in one presence of sufficient water for the enzymatic reaction to proceed, are stirred and heated between 50°C and 60°C under a vacuum of 9 to 15 mbars for 2 to 8 hours. The reaction is stopped by removing the enzyme by filtration. The resulting oil is submitted to two short path distillations. In the first one, which is carried between 50°C and 60°C removes excess 2- (2-butoxy ethoxy) ethanol as the distillate. The distilland from this first distillation is distilled again at 100-120°C and gives rise to an odourless distillate. Both distillations are carried out a pressure of 10"3 mbars. Analysis by gas chromatography reveals that a concentration of AA ethyl ester higher than 95% can be reached.
Example 6.
100 parts by weight of fatty acid ethyl esters containing 23% γ-linolenic acid (from borage oil) is transesterified with 600 to 800 parts by weight of 2- (2-butoxy ethoxy) ethanol and 6 to 10 parts of Lipozyme IM or lipase D from Rhizopus delemar or esterase 30000 from Mucor mihei strains, in one presence of sufficient water for the enzymatic reaction to proceed, under a vacuum of 9 to 15 mbars and at a temperature of 50-60°C. The reaction is stopped by removing the enzyme by filtration. The resulting oil is submitted to two short path distillations. In the first one, performed between 50°C and 60°C, excess alcohol is removed as distillate. The distilland residue thus obtained is subjected to a second distillation at 100-120°C. Both distillations are carried out at a pressure of 10"3 mbar. The distillate is recovered and analysed by gas chromatography. A clear odourless oil is obtained, which contains no less than 50% γ-linolenic acid ethyl ester. This concentration can reach 90%.
Example 7.
A mixture of fatty acid ethyl esters from evening primrose oil is treated under the same conditions as in Example 4. After a few hours (between 2 and 4), the reaction is stopped and the oil treated as in Example . The product comprises a γ-linolenic acid ethyl ester concentrate containing between 25% and 40%. This concentration can be dramatically increased when longer reaction times are applied.

Claims

What is claimed is:
1. A process for the separation and recovery of long chain fatty acids, including mono-and polyunsaturated fatty acids, derived from at least one natural oil as the triglyceride esters thereof, which process comprises at least the following steps:
(i) subjecting the oil to a transesterification reaction with a lower alkyl alcohol in the presence of an alkali metal alcoholate of the same lower alkyl alcohol as catalyst under an inert atmosphere at room temperature, and recovering the thus formed ethyl esters;
(ii) subjecting the ethyl esters from step (i) to short path distillation at 130-160°C and a pressure of 10~3 mbar to separate the mixture into two fractions comprising a distillate which is rich in lower alkyl esters of fatty acids possessing 18 carbons or less, and a distilland which is rich in esters of fatty acids possessing 20 carbons or more;
(iii) subjecting the fraction from step (ii) containing the desired purified fatty acid lower alkyl ester to a transesterification reaction with a mono- or poly-alkoxy primary alcohol catalysed by a reaction specific lipase, to provide a mixture of fatty acid ethyl esters rich in polyunsaturated fatty acids and fatty acid alkoxyalkyl esters rich in saturated and monounsaturated fatty acids;
(iv) removing the unreacted mono- or poly-alkoxy alcohol remaining after the transesterification reaction in step
(iii)by either short path distillation at 60-90°C under a pressure of 10"3 mbar, or by washing with water followed by drying;
(v) subjecting the esters mixture from step (iv)to short path distillation at 100-180°C to provide two fractions, comprising the fatty acid lower alkyl esters as distillate, and the fatty acid alkoxy alkyl esters as distilland; and (vi) recovering the desired fatty acid from the relevant fraction from step (v) .
2. A process according to Claim 1 further including between steps (i) and (ii) subjecting the mixture of lower alkyl esters to a short path distillation at 160-190°C and a pressure of 10"3 mbar to provide two fractions comprising a distillate which contains the desired fatty acid ethyl esters, and a distilland which is rejected.
3. A process according to Claim 1 in which the desired fatty acid is γ-linolenic acid derived from borage oil in which step (ii) is omitted.
4. A process according to Claim 1 wherein the lower alkyl alcohol is ethanol.
5. A process according to Claim 1 wherein the alkali metal in the alkali metal lower alkyl alcoholate is sodium.
6. A process according to Claim 1 wherein in step (i) the inert atmosphere comprises nitrogen.
7. A process according to Claim 1 wherein in step (iii) a monoalkoxy alcohol is used.
8. A process according to Claim 7 wherein the mono alkoxy primary alcohol has the general formula R-O- (CH2) n-CH20H, where n is 1, 2 or 3 and R includes 1 to 18 carbon atoms and is chosen from an alkyl group, and an alkyl group including one or two aromatic rings.
9. A process according to Claim 1 wherein in step (iii) a polyalkoxy alcohol is used.
10. A process according to Claim 9 wherein the polyalkoxy primary alcohol has the general formula R-0 (CH2-CH20) n-CH2CH2OH, in which n is from 0 to 10 and R includes 1 to 18 carbon atoms and is chosen from an alkyl group, and an alkyl group including one or two aromatic rings .
11. A process according to Claim 1 wherein the lipase enzyme is chosen to catalyse preferentially the transesterification of esters of saturated or mono unsaturated fatty acids.
12. A process according to Claim 11 wherein the lipase enzyme is chosen from the group consisting of: Lipozyme IM from a Mucor miehei strain; Lipase D from a Rhizopus del emar strain; and Esterase 30000 from a Mucor miehei strain.
13. A process according to Claim 1 wherein the enzyme is used either as a crude preparation or immobilized on a suitable support .
14. A process according to Claim 1 wherein step (iii) is carried out by stirring the alkyl ester preparation, the alcohol and the enzyme under vacuum of 0.1 mbars to 20 mbars. and at a temperature from 50°C to 70°C.
15. A process according to Claim 1 wherein the primary lower alkyl alcohol contains up to 7 carbon atoms, or is benzyl alcohol.
16. A process according to Claim 1 wherein the amount of water is from 1% to 10% by weight.
17. A process according to Claim 1 wherein in step (iii) the weight ratio of alkyl ester to be transesterified and alkoxy alcohol is from 4:1 to 1:1.
18. A process according to Claim 1 wherein in step (iii) the amount of enzyme used is between 0.5% to 5% by weight of the esters to be transesterified.
19. A process according to Claim 15 wherein the primary lower alcohol is ethanol.
PCT/CA2000/000643 1999-05-31 2000-05-31 Concentration and purification of polyunsaturated fatty acid esters by distillation-enzymatic transesterification coupling WO2000073254A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP00938359A EP1100764A1 (en) 1999-05-31 2000-05-31 Concentration and purification of polyunsaturated fatty acid
JP2000621321A JP2003500082A (en) 1999-05-31 2000-05-31 Concentration and purification of polyunsaturated fatty acid esters by a combination of distillation-enzymatic transesterification
AU53774/00A AU5377400A (en) 1999-05-31 2000-05-31 Concentration and purification of polyunsaturated fatty acid esters by distillation-enzymatic transesterification coupling

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002273570A CA2273570A1 (en) 1999-05-31 1999-05-31 Concentration and purification of polyunsaturated fatty acid esters by distillation-enzymatic transesterification coupling
CA2,273,570 1999-05-31

Publications (1)

Publication Number Publication Date
WO2000073254A1 true WO2000073254A1 (en) 2000-12-07

Family

ID=4163590

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2000/000643 WO2000073254A1 (en) 1999-05-31 2000-05-31 Concentration and purification of polyunsaturated fatty acid esters by distillation-enzymatic transesterification coupling

Country Status (5)

Country Link
EP (1) EP1100764A1 (en)
JP (1) JP2003500082A (en)
AU (1) AU5377400A (en)
CA (1) CA2273570A1 (en)
WO (1) WO2000073254A1 (en)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004043894A1 (en) * 2002-11-14 2004-05-27 Pronova Biocare As Lipase-catalysed esterification of marine oil
WO2007149577A2 (en) * 2006-06-23 2007-12-27 The Procter & Gamble Company Concentrated and odorless omega 3 fatty acids
EP1978102A1 (en) 2007-04-02 2008-10-08 Cognis IP Management GmbH A mixture containing fatty acid glycerides
EP1978101A1 (en) 2007-04-02 2008-10-08 Cognis IP Management GmbH Method for enriching polyunsaturated fatty acids
WO2009006317A1 (en) 2007-06-29 2009-01-08 Martek Biosciences Corporation Production and purification of esters of polyunsaturated fatty acids
WO2009020406A1 (en) * 2007-08-07 2009-02-12 Granate Seed Limited Methods of making lipid substances, lipid substances made thereby and uses thereof
WO2009154369A2 (en) * 2008-06-20 2009-12-23 에이케이바이오텍 주식회사 High-purity purification method for omega-3 highly unsaturated fatty acids
US7666666B2 (en) * 2004-09-20 2010-02-23 Sunho Biodiesel Corporation Fuel production
US7678930B2 (en) 2002-07-11 2010-03-16 Pronova Biopharma Norge As Process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
US7718698B2 (en) 2002-07-11 2010-05-18 Pronova Biopharma Norge As Process for decreasing environmental pollutants in an oil or a fat
WO2011072346A1 (en) * 2009-12-17 2011-06-23 Npc Indústrias Químicas Ltda. Process for modifying vegetable oils and primary plasticizer for vinyl polymers
WO2012130961A1 (en) * 2011-03-30 2012-10-04 Novozymes A/S Esterification process
US8420349B2 (en) 2007-07-12 2013-04-16 Ocean Nutrition Canada Limited Enzymatic modification of oil
FR2994696A1 (en) * 2012-05-29 2014-02-28 Roquette Freres CONTINUOUS PROCESS FOR ENRICHING DHA WITH ETHYL ESTERS OF AN OIL PRODUCED BY MICROALGUES
US8951761B2 (en) 2005-06-16 2015-02-10 Dsm Nutritional Products Ag Immobilized enzymes and methods of using thereof
US20150057353A1 (en) * 2006-07-05 2015-02-26 Photonz Corporation Limited production of ultrapure EPA and polar lipids form largely heterotrophic culture
EP2172558A4 (en) * 2007-07-30 2015-05-27 Nippon Suisan Kaisha Ltd Method for production of epa-enriched oil and dha-enriched oil
US9079847B2 (en) 2010-01-27 2015-07-14 Basf Pharma (Callanish) Limited Process for preparing and purifying fatty acids
CN107043794A (en) * 2017-06-12 2017-08-15 浙江工业大学 A kind of method that enzymatic safflower oil alcoholysis prepares fatty-acid ethyl ester
US10041097B2 (en) 2003-12-30 2018-08-07 Dsm Ip Assets B.V. Deaeration process
US10119098B2 (en) 2005-05-23 2018-11-06 Epax Norway As Concentration of fatty acid alkyl esters by enzymatic reactions with glycerol
US10240172B2 (en) * 2013-08-30 2019-03-26 Bizen Chemical Co., Ltd. Method for producing high purity omega-3 fatty acid ethyl ester
WO2021191385A1 (en) * 2020-03-27 2021-09-30 Polaris Method of fractionating fatty acids having two different carbons by molecular distillation
EP3890719A4 (en) * 2018-12-06 2022-08-24 Epax Norway AS Very long chain fatty acid compositions
CN115976125A (en) * 2022-12-02 2023-04-18 河北康睿达脂质有限公司 Structured lipid, method for producing same, structured fat emulsion, and structured fat emulsion preparation

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5450954B2 (en) * 2007-12-10 2014-03-26 日本水産株式会社 Method for producing fatty acid lower alcohol ester
CL2009001343A1 (en) * 2009-06-02 2009-07-10 Golden Omega S A Process of obtaining concentrated esters of epa and dha from marine oil, which includes adding to the alkali oil and water at less than 100 degrees Celsius, adding solvent, separating refining phase, adding acid, separating the non-aqueous phase and adding alcohol and a catalyst at less than 150 degrees Celsius, desolventilize and distill.
KR101815110B1 (en) 2015-10-16 2018-01-10 에이케이 앤 엠엔 바이오팜 주식회사 Purification and concentration method of omega-7 unsaturated fatty acids
CN109053438A (en) * 2018-06-28 2018-12-21 菏泽中禾健元生物科技有限公司 A method of improving conjugated linoleic acid glyceride production efficiency
CN114127043A (en) * 2019-07-17 2022-03-01 阿尔萨达股份公司 Process for the preparation of decolorized acetoacetylated glycols

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675132A (en) * 1985-03-28 1987-06-23 The United States Of America As Represented By The Secretary Of Commerce Polyunsaturated fatty acids from fish oils
US5747434A (en) * 1994-09-07 1998-05-05 Raisio Yhtyma Oyj Enzymatic process for preparing a synthetic ester from a vegetable oil

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675132A (en) * 1985-03-28 1987-06-23 The United States Of America As Represented By The Secretary Of Commerce Polyunsaturated fatty acids from fish oils
US5747434A (en) * 1994-09-07 1998-05-05 Raisio Yhtyma Oyj Enzymatic process for preparing a synthetic ester from a vegetable oil

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HAAS, M. J., AND SCOTT, K. M.: "Combined Nonenzymatic-Enzymatic Method for the Synthesis of Simple Alkyl Fatty Acid Esters from Soapstock", JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY., vol. 73, no. 11, 1997, AMERICAN OIL CHEMISTS' SOCIETY. CHAMPAIGN., US, pages 1393 - 1401, XP002147540, ISSN: 0003-021X *
SHIMADA, ET AL.: "Enrichment of Ethyl Docosahexaenoate by Selective Alcoholysis with Immobilised Rhizopus delemar Lipase", JOURNAL OF FERMENTATION AND BIOENGINEERING., vol. 84, no. 2, 1997, SOCIETY OF FERMENTATION TECHNOLOGY., JP, pages 138 - 143, XP000946079, ISSN: 0922-338X *
SHIMADA, Y., ET AL.: "Large-Scale Purification of gamma- Linolenic Acid by Selective Esterification Using Rhizopus delemar Lipase", JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY., vol. 75, no. 11, 1998, AMERICAN OIL CHEMISTS' SOCIETY. CHAMPAIGN., US, pages 1539 - 1544, XP002147542, ISSN: 0003-021X *
SHIMADA, Y., ET AL.: "Purification of Ethyl Docosahexaenoate by Selective Alcoholysis of Fatty Acid Ethyl Esters with Immobilized Rhizomucor miehei Lipase", JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY., vol. 75, no. 11, 1998, AMERICAN OIL CHEMISTS' SOCIETY. CHAMPAIGN., US, pages 1565 - 1571, XP002147541, ISSN: 0003-021X *

Cited By (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732488B2 (en) 2002-07-11 2010-06-08 Pronova Biopharma Norge As Pharmaceutical composition comprising low concentrations of environmental pollutants
US7718698B2 (en) 2002-07-11 2010-05-18 Pronova Biopharma Norge As Process for decreasing environmental pollutants in an oil or a fat
US7678930B2 (en) 2002-07-11 2010-03-16 Pronova Biopharma Norge As Process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
EP1534807B2 (en) 2002-07-11 2016-06-15 Pronova BioPharma Norge AS A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
US7491522B2 (en) 2002-11-14 2009-02-17 Pronova Biocare As Lipase-catalysed esterification of marine oil
JP2006506483A (en) * 2002-11-14 2006-02-23 プロノヴァ・バイオケア・アーエス Lipase catalyzed esterification of marine oil
CN100338010C (en) * 2002-11-14 2007-09-19 普罗诺瓦·比奥凯尔有限公司 Lipase-catalysed esterification of marine oil
WO2004043894A1 (en) * 2002-11-14 2004-05-27 Pronova Biocare As Lipase-catalysed esterification of marine oil
EP2602308A3 (en) * 2002-11-14 2014-04-02 Pronova BioPharma Norge AS Lipase-catalysed esterification of marine oil
US10041097B2 (en) 2003-12-30 2018-08-07 Dsm Ip Assets B.V. Deaeration process
US7666666B2 (en) * 2004-09-20 2010-02-23 Sunho Biodiesel Corporation Fuel production
US10119098B2 (en) 2005-05-23 2018-11-06 Epax Norway As Concentration of fatty acid alkyl esters by enzymatic reactions with glycerol
US8951761B2 (en) 2005-06-16 2015-02-10 Dsm Nutritional Products Ag Immobilized enzymes and methods of using thereof
WO2007149577A3 (en) * 2006-06-23 2008-03-27 Procter & Gamble Concentrated and odorless omega 3 fatty acids
WO2007149577A2 (en) * 2006-06-23 2007-12-27 The Procter & Gamble Company Concentrated and odorless omega 3 fatty acids
US20150057353A1 (en) * 2006-07-05 2015-02-26 Photonz Corporation Limited production of ultrapure EPA and polar lipids form largely heterotrophic culture
EP1978101A1 (en) 2007-04-02 2008-10-08 Cognis IP Management GmbH Method for enriching polyunsaturated fatty acids
EP1978102A1 (en) 2007-04-02 2008-10-08 Cognis IP Management GmbH A mixture containing fatty acid glycerides
US7737289B2 (en) 2007-04-02 2010-06-15 Cognis Ip Management Gmbh Process for enriching polyunsaturated fatty acids
US9796658B2 (en) 2007-06-29 2017-10-24 Dsm Ip Assets B.V. Production and purification of esters of polyunsaturated fatty acids
EP2173699A1 (en) * 2007-06-29 2010-04-14 Martek Biosciences Corporation Production and purification of esters of polyunsaturated fatty acids
WO2009006317A1 (en) 2007-06-29 2009-01-08 Martek Biosciences Corporation Production and purification of esters of polyunsaturated fatty acids
EP2173699A4 (en) * 2007-06-29 2014-04-16 Dsm Ip Assets Bv Production and purification of esters of polyunsaturated fatty acids
AU2014202880B2 (en) * 2007-06-29 2017-08-31 Dsm Ip Assets B.V. Production and purification of esters of polyunsaturated fatty acids
US8420349B2 (en) 2007-07-12 2013-04-16 Ocean Nutrition Canada Limited Enzymatic modification of oil
US11649473B2 (en) 2007-07-12 2023-05-16 Dsm Nutritional Products Ag Enzymatic modification of oil
US9885068B2 (en) 2007-07-12 2018-02-06 Dsm Ip Assets B.V. Enzymatic modification of oil
US9556401B2 (en) 2007-07-30 2017-01-31 Nippon Suisan Kaisha, Ltd. Method for producing EPA-enriched oil and DHA-enriched oil
EP2172558A4 (en) * 2007-07-30 2015-05-27 Nippon Suisan Kaisha Ltd Method for production of epa-enriched oil and dha-enriched oil
WO2009020406A1 (en) * 2007-08-07 2009-02-12 Granate Seed Limited Methods of making lipid substances, lipid substances made thereby and uses thereof
US20110091947A1 (en) * 2008-06-20 2011-04-21 Ak Biotech Co., Ltd. High-Purity Purification Method for Omega-3 Highly Unsaturated Fatty Acids
WO2009154369A2 (en) * 2008-06-20 2009-12-23 에이케이바이오텍 주식회사 High-purity purification method for omega-3 highly unsaturated fatty acids
WO2009154369A3 (en) * 2008-06-20 2010-03-11 에이케이바이오텍 주식회사 High-purity purification method for omega-3 highly unsaturated fatty acids
US8802877B2 (en) 2009-12-17 2014-08-12 Npc Industrias Quimicas Ltda Process for modifying vegetable oils and primary plasticizer for vinyl polymers
WO2011072346A1 (en) * 2009-12-17 2011-06-23 Npc Indústrias Químicas Ltda. Process for modifying vegetable oils and primary plasticizer for vinyl polymers
US9079847B2 (en) 2010-01-27 2015-07-14 Basf Pharma (Callanish) Limited Process for preparing and purifying fatty acids
WO2012130961A1 (en) * 2011-03-30 2012-10-04 Novozymes A/S Esterification process
WO2013178936A3 (en) * 2012-05-29 2014-05-08 Roquette Freres Method for continuously enriching an oil produced by microalgae with ethyl esters of dha
KR102148333B1 (en) * 2012-05-29 2020-08-26 로께뜨프레르 Method for continuously enriching an oil produced by microalgae with ethyl esters of dha
US9303231B2 (en) 2012-05-29 2016-04-05 Roquette Freres Method for continuously enriching an oil produced by microalgae with ethyl esters of DHA
US20150159116A1 (en) * 2012-05-29 2015-06-11 Roquette Freres Method for continuously enriching an oil produced by microalgae with ethyl esters of dha
CN104394702A (en) * 2012-05-29 2015-03-04 罗盖特兄弟公司 Method for continuously enriching an oil produced by microalgae with ethyl esters of dha
CN108624393A (en) * 2012-05-29 2018-10-09 罗盖特兄弟公司 Method for being constantly enriched with a kind of oil generated by microalgae, with DHA ethyl ester
KR20150021920A (en) * 2012-05-29 2015-03-03 로께뜨프레르 Method for continuously enriching an oil produced by microalgae with ethyl esters of dha
FR2994696A1 (en) * 2012-05-29 2014-02-28 Roquette Freres CONTINUOUS PROCESS FOR ENRICHING DHA WITH ETHYL ESTERS OF AN OIL PRODUCED BY MICROALGUES
US10240172B2 (en) * 2013-08-30 2019-03-26 Bizen Chemical Co., Ltd. Method for producing high purity omega-3 fatty acid ethyl ester
CN107043794A (en) * 2017-06-12 2017-08-15 浙江工业大学 A kind of method that enzymatic safflower oil alcoholysis prepares fatty-acid ethyl ester
EP3890719A4 (en) * 2018-12-06 2022-08-24 Epax Norway AS Very long chain fatty acid compositions
WO2021191385A1 (en) * 2020-03-27 2021-09-30 Polaris Method of fractionating fatty acids having two different carbons by molecular distillation
FR3108622A1 (en) * 2020-03-27 2021-10-01 Polaris Process for the fractionation of fatty acids with two carbon differences by molecular distillation
CN115976125A (en) * 2022-12-02 2023-04-18 河北康睿达脂质有限公司 Structured lipid, method for producing same, structured fat emulsion, and structured fat emulsion preparation
CN115976125B (en) * 2022-12-02 2023-11-07 河北康睿达脂质有限公司 Structured lipid, method for producing the same, structured fat emulsion, and structured fat emulsion preparation

Also Published As

Publication number Publication date
CA2273570A1 (en) 2000-11-30
JP2003500082A (en) 2003-01-07
AU5377400A (en) 2000-12-18
EP1100764A1 (en) 2001-05-23

Similar Documents

Publication Publication Date Title
WO2000073254A1 (en) Concentration and purification of polyunsaturated fatty acid esters by distillation-enzymatic transesterification coupling
AU757203B2 (en) Lipase-catalysed esterification of marine oil
AU686348B2 (en) Refining oil compositions
EP1560803B1 (en) Lipase-catalysed esterification of marine oil
JP4290162B2 (en) Process for producing symmetrical triglycerides
KR102148333B1 (en) Method for continuously enriching an oil produced by microalgae with ethyl esters of dha
EP2659780B2 (en) Omega 3 concentrate
CA2803477A1 (en) Process for separating polyunsaturated fatty acids from long chain unsaturated or less saturated fatty acids
JP3798467B2 (en) Enzymatic fractionation of highly unsaturated fatty acids
GB2350610A (en) Preparation of pure unsaturated fatty acids
JPH11116983A (en) Oil containing highly unsaturated fatty acid and obtained from scallop mid-gut gland and its production
JP4079516B2 (en) Method for producing triglyceride
JP3340182B2 (en) Method for producing triglyceride containing docosahexaenoic acid
JPH08214892A (en) Production of partial glyceride containing highly unsaturated fatty acid
JP3734905B2 (en) Method for purifying omega-3 polyunsaturated fatty acids
JP3880095B2 (en) Method for purifying highly unsaturated fatty acids
JP2000023689A (en) Concentration of compound in trans-10 isomer
EP1978101A1 (en) Method for enriching polyunsaturated fatty acids
KR101589825B1 (en) Method of enrichment highly purified stearidonic acid form from echium oil
JP2006288404A (en) Method for producing diglyceride
EP0964058B1 (en) Process for the enrichment of compounds in trans-10 isomers
JP2024004585A (en) METHOD FOR PRODUCING ω-3 POLYUNSATURATED FATTY ACID-CONTAINING COMPOSITION
JPS6312289A (en) Production of gamma-linolenic acid glyceride
JPS60234589A (en) Production of oil or fat
EP3317385A1 (en) Method for preparing 2-monoacylglycerides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2000938359

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000938359

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000938359

Country of ref document: EP